Broadway Financial Reports $25.9M Goodwill Impairment, Material Weaknesses, and Sharp Rise in Non-Accrual Loans
BYFC sits 50% above its 52-week low of $5.51 on light trading volume (0.2× avg).
Summary
Broadway Financial reported a significant net loss for Q3 2025, driven by a $25.9 million goodwill impairment charge. The company also disclosed material weaknesses in its internal controls over financial reporting and a substantial increase in non-accrual loans.
Key Events · Legal and Risk Events · BYFC
-
Goodwill Impairment
The company recorded a $25.9 million non-cash goodwill impairment charge for the third quarter of 2025, reflecting a significant write-down of prior acquisition value.
-
Material Weaknesses in Internal Controls
Management identified material weaknesses in internal control over financial reporting, specifically related to the accounting for loan participations, identification of unusual equity-related contracts, and evaluation of collateral-dependent loans.
-
Sharp Increase in Non-Accrual Loans
Non-accrual loans surged to $13.5 million at September 30, 2025, a substantial increase from $264 thousand at December 31, 2024, indicating a significant deterioration in asset quality.
-
Net Loss Attributable to Common Stockholders
The company reported a net loss attributable to common stockholders of $24.6 million for Q3 2025 and $28.1 million for the first nine months of 2025, largely driven by the goodwill impairment.
Analysis · BYFC · Finance
This 10-Q filing reveals severe financial and operational challenges for Broadway Financial. The $25.9 million goodwill impairment represents a substantial write-down of asset value, indicating that prior acquisitions are not performing as expected. Coupled with the disclosure of material weaknesses in internal controls over financial reporting, this raises significant concerns about the company's financial integrity and risk management. The dramatic increase in non-accrual loans further highlights a deteriorating asset quality trend, which could lead to higher future credit losses. Investors should view these disclosures as highly negative signals, suggesting fundamental issues that could impact future profitability and shareholder value. The ongoing need for restatements underscores a persistent lack of reliable financial reporting.
At the time of this filing, BYFC was trading at $8.25 on NASDAQ in the Finance sector, with a market capitalization of approximately $75.7M. The 52-week trading range was $5.51 to $9.46. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.